U.S. market Closed. Opens in 2 days 6 hours 6 minutes

IKNA | Ikena Oncology, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue9.16M15.62M30.98M9.19M13.75M
Cost of Revenue1.02M2.03M47.11M44.85M24.94M
Gross Profit8.14M13.58M-16.12M-35.65M-11.19M
Operating Expenses83.56M86.52M65.12M53.71M32.24M
Selling, General & Admin24.93M22.20M18.02M8.87M7.31M
Research & Development58.63M64.32M47.11M44.85M24.94M
Other Operating Expenses-22.00K-10.00K23.00K263.00K1.68M
Operating Income-75.42M-70.90M-34.14M-44.52M-18.49M
Other Expenses / Income7.09M2.14M23.00K263.00K1.68M
Before Tax Income-68.33M-68.77M-34.12M-44.26M-16.82M
Income Tax Expenses-162.00K-2.14M307.44K93.70K71.14K
Net Income-68.17M-66.63M-34.12M-44.26M-16.82M
Interest ExpensesN/A2.15MN/AN/AN/A
Basic Shares Outstanding41.74M36.19M35.98M35.85M35.85M
Diluted Shares Outstanding41.74M36.19M35.98M35.85M35.85M
EBITDA-74.40M-70.15M-33.59M-44.22M-18.25M
EBITDA Margin-812.19%-449.18%-108.42%-480.95%-132.69%
EBIT-68.33M-66.62M-33.81M-44.16M-16.75M
EBIT Margin-745.94%-426.53%-109.11%-480.34%-121.76%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙